The 8th Annual TIL Therapies Summit brings together experts to advance tumor-infiltrating lymphocyte (TIL) therapies through clinical innovation, optimized manufacturing, and improved therapeutic precision for better patient outcomes.
Key Topics
Next-generation engineering of TIL therapies for enhanced safety and persistence
Optimization of cell banking pathways for improved efficacy
Development of innovative combination strategies for clinical success
Acceleration of manufacturing processes to reduce patient wait times
Exploration of tumor immunity and resistance mechanisms
Integration of biomarkers and translational research for clinical optimization
Regulatory and clinical adoption strategies for TIL implementation
Operational management of patient treatment and side effects
Pre-treatment insights and engineering advances for safe TIL expansion
